Andersons pediatric cardiology 2376
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (100.55 KB, 3 trang )
chestradiography,498
computedtomographyangiographyin,498
courseandprognosisof,500
differentialdiagnosisof,500
echocardiography,498,499f
electrocardiographyin,498
etiologyof,496
lungtransplant,500–501
magneticresonanceimagingin,498
managementof,500
ofmostorallpulmonaryveins,500
ofoneortwopulmonaryveins,500
pathophysiologyof,497–498
presentationandsymptomsof,498
radionuclideangiographyin,498
traditionalangiographyin,499–500,499f
Pulmonaryveins
indiagnosticcatheterization,249
echocardiographicquantificationandidentificationofpatternsofflowin,303,304f
Pulmonaryvenoocclusivedisease,pulmonaryhypertensionand,1386
Pulmonaryvenousanomalies,475–501
anomalouspulmonary-to-systemiccollateralveinsandlevoatrialcardinalveinas,496,496f–497f
anomalousvenoatrialconnections,withisomericatrialappendages,443–444
atresiaofcommonpulmonaryveinas,490
anatomyof,490,494f
clinicalpresentationandinvestigationof,490
imagingof,490
managementof,490
pathophysiologyof,490
stenosisoratresiaas,496–501
anatomyof,496,497f,499f
cardiaccatheterizationin,498–499
catheter-basedinterventions,500
chestradiography,498
computedtomographyangiographyin,498
courseandprognosisof,500
differentialdiagnosisof,500
echocardiography,498,499f
electrocardiographyin,498
etiologyof,496
lungtransplant,500–501
magneticresonanceimagingin,498
managementof,500
ofmostorallpulmonaryveins,500
ofoneortwopulmonaryveins,500
pathophysiologyof,497–498
presentationandsymptomsof,498
radionuclideangiographyin,498
traditionalangiographyin,499–500,499f
unilateralpulmonaryvenousatresiaas,490–491
Pulmonaryvenousobstruction
consequencesof,totallyanomalouspulmonaryvenousconnection,480
pulmonaryhypertensionassociatedwith,1386
totallyanomalouspulmonaryveinconnectionand,480
Pulmonaryvenousstenosis,interventionaltechniquesfor,273–275
foreignbodies,removalof,ordevicesfromthecirculation,274–275
stenting,ofarterialduct,274,274f
Pulmonary-to-systemicveins,anomalous,levoatrialcardinalveinand,496,
496f–497f
Pulsatilityindex,90,90f
Pulsecontouranalysis,1362
Pulseindexcontinuouscardiacoutputsystem,foracutecirculatoryfailure,1181
Pulseoximetry
inFontanpathway,1275,1288
forinterstagemanagement,1307
screening,1536–1537
Pulsetransittime,1365,1365f
Pulse-waveDoppler
echocardiography,284
optimizingsettingsfor,286
fetal,127–129
ofarterialduct,130,130f
ofatrioventricularvalves,131,132f
ofmiddlecerebralartery,129–130,130f
ofumbilicalartery,129,129f
ofumbilicalvein,130,131f
ofvenousduct,131,131f
Pulsewavevelocity(PWV),101–102,436,436f,1365
Pulselessdisease,cardiacinvolvementin,1109–1110
Pumps,incardiopulmonarybypass,226–227
Purkinjecelltumors,975–976
PWV,Pulsewavevelocity
Q
Qualityimprovement,incongenitalcardiacdisease,1505–1518
care
dataregistriesin,1510,1511t–1514t
datasourcesin,1509–1510
definingoutcomesin,1509
improvingoutcomesin,1510–1516
inimprovingoutcomes,roleoftransparency,1516–1518
modelfor,1505–1506,1506f
patientsandtheirfamilies,1505
targetsfor,1509
variationand,1506–1509,1507f–1508f
Qualityoflife
forchildrenwithcardiacdisease,1459
followingcardiactransplantation,1238
inFontan-associatedliverdisease,1335
projectionsanddefinitionsof,incongenitalheartdisease,164
Quantificationofvolume,101
Quantitativeechocardiography,302–305
quantificationofechocardiographicdimensionsusing,302,302f
quantificationofflowandidentificationofpatternsofflowusing,302–305
inabdominalaorta,303,303f
inatrioventricularvalves,304,304f
